SOFINNOVA PARTNERS is a management entity listed as a director and promoter on 2 SEC Form D filings by 2 issuers between Mar 2015 and Nov 2024: Sofinnova Capital XI SCSP SICAV-RAIF (Luxembourg, Luxembourg (as filed: N4) — pooled investment fund — 2024; $54M reported sold to 2 investors) and CERENIS THERAPEUTICS HOLDING S.A. (Labege, France (as filed: I0) — biotechnology — 2015; $4.12M reported sold to 13 investors).
What this means 2 separate companies raised money with this person listed as director and promoter, over about 9 years. Across those companies the filings report $58.1M sold in total.
All 2 issuers belong to the sponsor group Bridgepoint Direct (15 issuers, $289.6M reported sold, 2015–2026).
What this means A sponsor group is one team that sets up a new company for each deal. Bridgepoint Direct has 15 companies on file and $289.6M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 2 public filings for SOFINNOVA PARTNERS and found 1 difference: No amendment in the last 12 months on an offering that may still be open.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.